Statistics for The oral ferroportin inhibitor vamifeport improved hemodynamics in a mouse model of sickle cell disease.
Total visits
| views | |
|---|---|
| The oral ferroportin inhibitor vamifeport improved hemodynamics in a mouse model of sickle cell disease. | 31 |
Total visits per month
| views | |
|---|---|
| June 2024 | 0 |
| July 2024 | 0 |
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
File Visits
| views | |
|---|---|
| blood.2021014716.pdf | 50 |